Health Care/Hospital News & Press Release Distribution

The Sanitation and Hygiene Fund to be launched on 17 November

GENEVA, Switzerland, Nov. 12, 2020 /PRNewswire/ -- The Sanitation and Hygiene Fund will be launched during an online event next Tuesday. It is seekingUS$2 billion over the coming five years to provide a 21st-century solution to the decades-old crisis on sanitation, hygiene and menstrual health. ...

2020-11-12 08:00 1159

The Sanitation and Hygiene Fund to be launched on 17 November

Suh Kyungbae Science Foundation holds the first symposium

* Sharing the outcome of the research work of five young scientists selected in 2017 * Awarding certificates to three young scientists of 2020 SEOUL, South Korea, Nov. 12, 2020 /PRNewswire/ -- Suh Kyungbae Science Foundation (Chairman Suh Kyungbae) held the SUHF Symposium 2020 at Amore Hall, ...

2020-11-12 08:00 2106

Suh Kyungbae Science Foundation holds the first symposium

Spine Innovations gains its independence, aims for massive growth in sales of its ESP® Disc Replacements in Spine

HEIMSBRUNN, France, Nov. 11, 2020 /PRNewswire/ -- Following the acquisition of its parent company FH Ortho by Olympus Corporation, Spine Innovations has become a fully independent company — and dedicated itself to worldwide sales deployment of its ESP® disc replacements. This development demonstr...

2020-11-12 03:45 1163

Spine Innovations gains its independence, aims for massive growth in sales of its ESP® Disc Replacements in Spine

International Medical Group Appoints Guillermo Ortega as Chief Underwriting Officer

INDIANAPOLIS, Nov. 12, 2020 /PRNewswire/ -- International Medical Group® (IMG® ), an industry-leading international medical insurance, global assistance, and travel insurance company is pleased to announce thatGuillermo Ortega has joined the company as Chief Underwriting Officer. Guillermo will b...

2020-11-12 03:00 1479

OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines

* The collaboration will develop an innovative genomic-based clinical treatment platform * The goal of the collaboration is to accelerate the R&D and commercialization of innovative medicines SHANGHAI, Nov. 11, 2020 /PRNewswire/ --OrigiMed, a China-based leading precision medicine company and...

2020-11-11 21:26 6578

OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines

I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020

SHANGHAI and GAITHERSBURG, Md., Nov. 11, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced new preclinical data fromin vivo and in vitro studies of...

2020-11-11 21:00 5095

ISSA Global Biorisk Symposium Asean Announced The Symposium for Biorisk Mitigation & Infection Control

BANGKOK, Nov. 11, 2020 /PRNewswire/ -- Informa Markets in Thailand, the leading exhibition organiser, ISSA, the Worldwide Cleaning Industry Association and GBAC, a Division of ISSA have formed a strategic partnership to help cleaning professionals prepare for, respond to and recover from the nove...

2020-11-11 17:36 1681

ISSA Global Biorisk Symposium Asean Announced The Symposium for Biorisk Mitigation & Infection Control

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

2020-11-11 17:30 5968

Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702

SHANGHAI, Nov. 11, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company with global aspirations to discover, develop, and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today that the first patient was enrolled and a...

2020-11-11 17:08 1193

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

2020-11-11 16:09 4325

Monograph Published by World Scientific Publishing Proves Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer Effective in Treating COVID-19

SHANGHAI, Nov. 11, 2020 /PRNewswire/ -- Asclepius Meditec ("the Company") is pleased to announce that Hydrogen Oxygen Generator with Nebulizer – a respiratory medical device developed by the Company for combatting the coronavirus, has been featured in a monograph titled "Hydrogen-Oxygen Inhalati...

2020-11-11 16:07 2382

Monograph Published by World Scientific Publishing Proves Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer Effective in Treating COVID-19

SHANGHAI, Nov. 11, 2020 /PRNewswire/ -- Asclepius Meditec ("the Company") is pleased to announce that Hydrogen Oxygen Generator with Nebulizer – a respiratory medical device developed by the Company for combatting the coronavirus, has been featured in a monograph titled "Hydrogen-Oxygen Inhalati...

2020-11-11 15:58 1874

I Love Children Kick-starts Fertility Wellness Campaign 2020

SINGAPORE, Nov. 4, 2020 /PRNewswire/ -- I Love Children (ILC) announced today, the start of their annualKnow Your Fertility Wellness Campaign, which will continue their focus on educating couples on fertility health and creating conversations on the subject of fertility through virtual webinars w...

2020-11-11 15:00 1449

The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use

* The emergency use authorization is only granted for limited use during the pandemic, not as a product distribution approval * Data on quality, both non-clinical and clinical, as well as the public health risks are the main considerations JAKARTA, Indonesia, Nov. 11, 2020 /PRNewswire/ -- Eme...

2020-11-11 12:51 1317

The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use

Capnomed receives the Promising Startups in Asia Award at the ACES Awards 2020

STUTTGART, Germany, Nov. 11, 2020 /PRNewswire/ -- A new, inventive cutting-edge therapy (PIPAC - Pressurized IntraPeritoneal Aerosol Chemotherapy) is bringing hope to millions of cancer patients across the globe -- includingAsia. This treatment is performed using Capnomed's uniquely designed, pat...

2020-11-11 10:00 1994

Capnomed receives the Promising Startups in Asia Award at the ACES Awards 2020

Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians inAsia-Pacific with a holistic treatment approach for prediabetes and diabetes. This...

2020-11-11 10:00 3210

Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day

SAN FRANCISCO and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major diseas...

2020-11-11 08:00 7480

Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day

Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020

SAN FRANCISCO, U.S. and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other ma...

2020-11-11 08:00 6425

All Blacks Name Hyperice Official Recovery Technology Supplier

Partnership with Iconic New Zealand Rugby Teams Highlights Global Demand for In-Game Recovery Technology Access to Optimize Player Performance IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ -- Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic air comp...

2020-11-11 04:00 1595

All Blacks Name Hyperice Official Recovery Technology Supplier

Comet Bio Awarded by Frost & Sullivan for its Arrabina(TM) Prebiotic Fiber

Comet Bio's use of upcycled crop leftovers to produce Arrabina ™ addresses consumer demand for sustainably sourced, clean label ingredients SANTA CLARA, Calif., Nov. 11, 2020 /PRNewswire/ -- Based on its recent analysis of sustainable dietary fiber products for the North American food and bevera...

2020-11-11 01:15 1758